nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—Naloxone—TLR4—periodontitis	0.201	1	CrCbGaD
Naltrexone—OPRD1—Peptide GPCRs—CXCR2—periodontitis	0.0213	0.0267	CbGpPWpGaD
Naltrexone—OPRK1—Peptide GPCRs—CXCR2—periodontitis	0.0187	0.0234	CbGpPWpGaD
Naltrexone—OPRD1—Peptide GPCRs—CCR2—periodontitis	0.0166	0.0208	CbGpPWpGaD
Naltrexone—OPRM1—Peptide GPCRs—CXCR2—periodontitis	0.0158	0.0198	CbGpPWpGaD
Naltrexone—OPRD1—Peptide ligand-binding receptors—CXCL3—periodontitis	0.0156	0.0195	CbGpPWpGaD
Naltrexone—OPRK1—Peptide GPCRs—CCR2—periodontitis	0.0146	0.0182	CbGpPWpGaD
Naltrexone—ABCB1—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.0137	0.0172	CbGpPWpGaD
Naltrexone—OPRK1—Peptide ligand-binding receptors—CXCL3—periodontitis	0.0137	0.0171	CbGpPWpGaD
Naltrexone—OPRD1—G alpha (i) signalling events—CXCL3—periodontitis	0.0131	0.0164	CbGpPWpGaD
Naltrexone—OPRM1—Peptide GPCRs—CCR2—periodontitis	0.0123	0.0154	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—CXCL3—periodontitis	0.0115	0.0144	CbGpPWpGaD
Naltrexone—OPRK1—G alpha (i) signalling events—CXCL3—periodontitis	0.0115	0.0144	CbGpPWpGaD
Naltrexone—OPRM1—TCR Signaling Pathway—IL17A—periodontitis	0.011	0.0138	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0105	0.0131	CbGpPWpGaD
Naltrexone—OPRM1—IL4-mediated signaling events—IL10—periodontitis	0.0101	0.0126	CbGpPWpGaD
Naltrexone—OPRD1—Peptide ligand-binding receptors—CXCR2—periodontitis	0.01	0.0126	CbGpPWpGaD
Naltrexone—OPRM1—IL4-mediated signaling events—IL4—periodontitis	0.00982	0.0123	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—CXCL3—periodontitis	0.00974	0.0122	CbGpPWpGaD
Naltrexone—UGT1A1—Phase II conjugation—GGT1—periodontitis	0.00945	0.0118	CbGpPWpGaD
Naltrexone—OPRK1—Mecp2 and Associated Rett Syndrome—FGF2—periodontitis	0.00917	0.0115	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00916	0.0115	CbGpPWpGaD
Naltrexone—OPRK1—Peptide ligand-binding receptors—CXCR2—periodontitis	0.0088	0.011	CbGpPWpGaD
Naltrexone—OPRD1—G alpha (i) signalling events—CXCR2—periodontitis	0.00847	0.0106	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CXCL3—periodontitis	0.00796	0.00996	CbGpPWpGaD
Naltrexone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00788	0.00985	CbGpPWpGaD
Naltrexone—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00786	0.00983	CbGpPWpGaD
Naltrexone—OPRD1—Peptide ligand-binding receptors—CCR2—periodontitis	0.00781	0.00977	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00774	0.00969	CbGpPWpGaD
Naltrexone—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	0.00771	0.00965	CbGpPWpGaD
Naltrexone—OPRM1—TCR Signaling Pathway—IL1A—periodontitis	0.00754	0.00943	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—CXCR2—periodontitis	0.00744	0.00931	CbGpPWpGaD
Naltrexone—OPRK1—G alpha (i) signalling events—CXCR2—periodontitis	0.00743	0.00929	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CXCL3—periodontitis	0.00698	0.00873	CbGpPWpGaD
Naltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00689	0.00862	CbGpPWpGaD
Naltrexone—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	0.00688	0.00861	CbGpPWpGaD
Naltrexone—OPRK1—Peptide ligand-binding receptors—CCR2—periodontitis	0.00685	0.00857	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00673	0.00843	CbGpPWpGaD
Naltrexone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.00664	0.00831	CbGpPWpGaD
Naltrexone—OPRD1—G alpha (i) signalling events—CCR2—periodontitis	0.00659	0.00824	CbGpPWpGaD
Naltrexone—UGT1A1—NRF2 pathway—GGT1—periodontitis	0.00631	0.00789	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—CXCR2—periodontitis	0.00628	0.00785	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL13—periodontitis	0.00624	0.00781	CbGpPWpGaD
Naltrexone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00611	0.00765	CbGpPWpGaD
Naltrexone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00609	0.00761	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00591	0.00739	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CXCL3—periodontitis	0.0059	0.00738	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00583	0.00729	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—CCR2—periodontitis	0.00579	0.00724	CbGpPWpGaD
Naltrexone—OPRK1—G alpha (i) signalling events—CCR2—periodontitis	0.00578	0.00723	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL17A—periodontitis	0.00574	0.00718	CbGpPWpGaD
Naltrexone—UGT1A1—Biological oxidations—GGT1—periodontitis	0.00553	0.00692	CbGpPWpGaD
Naltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00536	0.00671	CbGpPWpGaD
Naltrexone—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	0.00535	0.00669	CbGpPWpGaD
Naltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00534	0.00668	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00524	0.00655	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00521	0.00652	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CXCR2—periodontitis	0.00513	0.00642	CbGpPWpGaD
Naltrexone—UGT1A1—NRF2 pathway—AGER—periodontitis	0.00502	0.00628	CbGpPWpGaD
Naltrexone—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	0.00499	0.00624	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00499	0.00624	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—CCR2—periodontitis	0.00488	0.00611	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00459	0.00575	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00457	0.00572	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00453	0.00567	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00451	0.00564	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CXCL3—periodontitis	0.0045	0.00563	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CXCR2—periodontitis	0.0045	0.00563	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CXCL3—periodontitis	0.00408	0.00511	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CCR2—periodontitis	0.00399	0.00499	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—ADRB1—periodontitis	0.00397	0.00497	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CXCL3—periodontitis	0.00394	0.00493	CbGpPWpGaD
Naltrexone—OPRM1—TCR Signaling Pathway—IL1B—periodontitis	0.00393	0.00492	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL1A—periodontitis	0.00393	0.00491	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL10—periodontitis	0.0039	0.00488	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00388	0.00486	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00386	0.00483	CbGpPWpGaD
Naltrexone—OPRD1—Peptide ligand-binding receptors—CCL2—periodontitis	0.00385	0.00481	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CXCR2—periodontitis	0.0038	0.00475	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL4—periodontitis	0.0038	0.00475	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CXCL3—periodontitis	0.00358	0.00448	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CCR2—periodontitis	0.0035	0.00438	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—ADRB1—periodontitis	0.00348	0.00436	CbGpPWpGaD
Naltrexone—ABCB1—HIF-1-alpha transcription factor network—NOS2—periodontitis	0.00346	0.00432	CbGpPWpGaD
Naltrexone—OPRK1—Peptide ligand-binding receptors—CCL2—periodontitis	0.00337	0.00422	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCL3—periodontitis	0.00333	0.00417	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—VIP—periodontitis	0.00325	0.00407	CbGpPWpGaD
Naltrexone—OPRM1—TCR Signaling Pathway—TGFB1—periodontitis	0.00306	0.00382	CbGpPWpGaD
Naltrexone—OPRD1—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00304	0.00381	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCL3—periodontitis	0.00303	0.00379	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CCR2—periodontitis	0.00296	0.0037	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—VIP—periodontitis	0.00295	0.00369	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—ADRB1—periodontitis	0.00294	0.00368	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CXCR2—periodontitis	0.0029	0.00363	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—SLC52A3—periodontitis	0.00289	0.00361	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—CCL2—periodontitis	0.00285	0.00357	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—VIP—periodontitis	0.00285	0.00357	CbGpPWpGaD
Naltrexone—OPRK1—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00267	0.00334	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CXCR2—periodontitis	0.00263	0.00329	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—VIP—periodontitis	0.00259	0.00324	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00258	0.00323	CbGpPWpGaD
Naltrexone—OPRD1—G alpha (i) signalling events—CXCL8—periodontitis	0.00257	0.00321	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CXCR2—periodontitis	0.00254	0.00318	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL3—periodontitis	0.00241	0.00302	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—VIP—periodontitis	0.00241	0.00301	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CXCR2—periodontitis	0.00231	0.00289	CbGpPWpGaD
Naltrexone—OPRM1—TCR Signaling Pathway—IL6—periodontitis	0.0023	0.00288	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IFNG—periodontitis	0.0023	0.00287	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00226	0.00283	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00225	0.00282	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CCR2—periodontitis	0.00225	0.00282	CbGpPWpGaD
Naltrexone—OPRK1—G alpha (i) signalling events—CXCL8—periodontitis	0.00225	0.00282	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—ADRB1—periodontitis	0.00224	0.00281	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.0022	0.00276	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—VIP—periodontitis	0.00219	0.00274	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCR2—periodontitis	0.00215	0.00269	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—CXCL8—periodontitis	0.00213	0.00267	CbGpPWpGaD
Naltrexone—UGT1A1—NRF2 pathway—TGFB1—periodontitis	0.00212	0.00265	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL3—periodontitis	0.00212	0.00265	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL1B—periodontitis	0.00205	0.00256	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CCR2—periodontitis	0.00205	0.00256	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00204	0.00255	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—ADRB1—periodontitis	0.00204	0.00255	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CCR2—periodontitis	0.00198	0.00247	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ADRB1—periodontitis	0.00197	0.00246	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CCL2—periodontitis	0.00197	0.00246	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCR2—periodontitis	0.00195	0.00244	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00191	0.00239	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—CXCL8—periodontitis	0.0019	0.00238	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCR2—periodontitis	0.00179	0.00225	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00179	0.00224	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL3—periodontitis	0.00179	0.00224	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ADRB1—periodontitis	0.00179	0.00224	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—VIP—periodontitis	0.00174	0.00218	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CCL2—periodontitis	0.00172	0.00216	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ACP5—periodontitis	0.0017	0.00213	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CCR2—periodontitis	0.00167	0.00209	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ADRB1—periodontitis	0.00166	0.00208	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—TGFB1—periodontitis	0.00159	0.00199	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCR2—periodontitis	0.00155	0.00195	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CXCL8—periodontitis	0.00155	0.00194	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—MMP3—periodontitis	0.00155	0.00194	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—VIP—periodontitis	0.00153	0.00191	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCR2—periodontitis	0.00152	0.0019	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00151	0.00189	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADRB1—periodontitis	0.00151	0.00189	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—TNF—periodontitis	0.00149	0.00186	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CCL2—periodontitis	0.00146	0.00182	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCR2—periodontitis	0.00136	0.00171	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CXCL8—periodontitis	0.00136	0.0017	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—MMP3—periodontitis	0.00136	0.0017	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—SLC52A3—periodontitis	0.00132	0.00166	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—VIP—periodontitis	0.00129	0.00162	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCR2—periodontitis	0.00121	0.00151	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.0012	0.00151	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADRB1—periodontitis	0.0012	0.00151	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCR2—periodontitis	0.00115	0.00144	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CXCL8—periodontitis	0.00115	0.00144	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—MMP3—periodontitis	0.00115	0.00144	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.00109	0.00136	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCR2—periodontitis	0.00106	0.00133	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADRB1—periodontitis	0.00106	0.00132	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CCL2—periodontitis	0.00101	0.00126	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NTRK1—periodontitis	0.000986	0.00123	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GGT1—periodontitis	0.000946	0.00118	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MMP3—periodontitis	0.000916	0.00115	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCR2—periodontitis	0.000896	0.00112	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADRB1—periodontitis	0.000892	0.00112	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCL2—periodontitis	0.000884	0.00111	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CXCL8—periodontitis	0.000878	0.0011	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NTRK1—periodontitis	0.000864	0.00108	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MMP3—periodontitis	0.000803	0.00101	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CXCL8—periodontitis	0.000797	0.000998	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000785	0.000982	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ACP5—periodontitis	0.00078	0.000976	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CXCL8—periodontitis	0.00077	0.000963	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCL2—periodontitis	0.000747	0.000935	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000733	0.000917	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NTRK1—periodontitis	0.00073	0.000914	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CXCL8—periodontitis	0.000699	0.000875	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MMP3—periodontitis	0.000679	0.00085	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PPARA—periodontitis	0.000677	0.000847	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	0.000663	0.00083	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCL8—periodontitis	0.000651	0.000814	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL2—periodontitis	0.000596	0.000745	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCL8—periodontitis	0.000591	0.000739	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—FGF2—periodontitis	0.000538	0.000674	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL2—periodontitis	0.000522	0.000654	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FGF2—periodontitis	0.000472	0.000591	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL8—periodontitis	0.000471	0.000589	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6—periodontitis	0.000448	0.00056	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL2—periodontitis	0.000442	0.000552	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTGS2—periodontitis	0.00044	0.000551	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GGT1—periodontitis	0.000434	0.000543	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MMP9—periodontitis	0.000426	0.000533	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL8—periodontitis	0.000413	0.000517	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FGF2—periodontitis	0.000399	0.000499	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6—periodontitis	0.000393	0.000491	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MMP9—periodontitis	0.000374	0.000467	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TGFB1—periodontitis	0.000351	0.000439	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL8—periodontitis	0.000349	0.000437	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6—periodontitis	0.000332	0.000415	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MMP9—periodontitis	0.000316	0.000395	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PPARA—periodontitis	0.000311	0.000389	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TGFB1—periodontitis	0.000308	0.000385	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6—periodontitis	0.000265	0.000331	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TGFB1—periodontitis	0.00026	0.000326	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6—periodontitis	0.000232	0.00029	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTGS2—periodontitis	0.000202	0.000253	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6—periodontitis	0.000196	0.000245	CbGpPWpGaD
